We are live on ! Find out more
BPTH

Bio-Path Holdings Inc
BPTH

Delisted

BPTH was delisted on the 18th of February, 2025.

Back to rankings

16 hedge funds and large institutions have $1.7M invested in Bio-Path Holdings Inc in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% less funds holding

Funds holding: 17 → 16 (-1)

24% less capital invested

Capital invested by funds: $2.23M → $1.7M (-$530K)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
16
Holders Change
-1
Holders Change %
-5.88%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
B
Bailard
California
+$155K
2
UBS Group
UBS Group
Switzerland
+$11.3K
3
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors
North Carolina
+$1.2K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$64K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$13.6K
3
BlackRock
BlackRock
New York
-$7.96K
4
Morgan Stanley
Morgan Stanley
New York
-$7.96K
5
TRCT
Tower Research Capital (TRC)
New York
-$7K

BPTH Hedge Fund Activity: Q4 2021 in Review

16 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q4 2021, worth a combined $1.7M — down 24% from $2.23M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of BPTH and 2 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 1 added.

The largest buyer was Bailard, opening a new position worth an estimated $155K. The largest seller was Citadel Advisors, exiting entirely with an estimated $64K sold.

  • 16 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q4 2021, down from 17 in Q3 2021.
  • Funds reported $1.7M of Bio-Path Holdings Inc stock for Q4 2021, down 24% quarter-over-quarter.
  • 2 funds opened new Bio-Path Holdings Inc positions in Q4 2021 and 3 closed out, a net change of -1 holder.
  • The largest Bio-Path Holdings Inc buyer in Q4 2021 was Bailard, an estimated $155K added.
  • The largest Bio-Path Holdings Inc seller in Q4 2021 was Citadel Advisors, an estimated $64K sold.

Based on aggregated 13F filings for Q4 2021.